A traditional Chinese medicine composition for treating ischemic stroke and its preparation method and application
By treating Chuanxiong with composite bacteria and enzymatic hydrolysis, the laccase method was used to enhance the extraction and efficacy of the active ingredients of the traditional Chinese medicine composition, forming a traditional Chinese medicine composition for treating deficiency, enhancing the extraction and efficacy of the active ingredients of the traditional Chinese medicine composition, enhancing the blood circulation and analgesic effects of the traditional Chinese medicine composition, reducing neurological dysfunction caused by cerebral ischemia, and protecting neurological damage caused by ischemic stroke.
Patent Information
- Application Number
- CN202411938688.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-26
- Publication Date
- 2025-09-19
- Estimated Expiration
- 2044-12-26
AI Technical Summary
Existing methods for extracting the active ingredients of Chuanxiong are not ideal, which affects its efficacy in treating ischemic stroke and lacks effective neuroprotective effects.
The method of composite bacterial fermentation and composite enzyme treatment is adopted to treat Chuanxiong, using Aconitum carlesioides, Lactobacillus plantarum and Bacillus subtilis to produce laccase, combined with cellulase and phospholipase to enhance the extraction of active ingredients and medicinal efficacy of Chuanxiong, thus forming a traditional Chinese medicine composition.
It significantly enhances the blood-activating and analgesic effects of the traditional Chinese medicine combination, alleviates neurological dysfunction caused by cerebral ischemia, and protects neurological damage caused by ischemic stroke.